Samsung Biologics
207940.KS
$559.32
Share price
-1.28%
Change (1 day)
-3.82%
Change (1 year)
Categories
Samsung Biologics (207940.KS) - Total debt
Total debt on the balance sheet as of December 2023 : $1.47 B
According to Samsung Biologics 's latest financial reports the company's total debt is $1.47 B. A company’s total debt is the sum of all current and non-current debts.
Samsung Biologics - Total debt on balance sheet (from 2016 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $1.47 B | -25.97% |
| 2022-12-31 | $1.99 B | 83.52% |
| 2021-12-31 | $1.08 B | 50.38% |
| 2020-12-31 | $0.72 B | 27.8% |
| 2019-12-31 | $0.56 B | -27.69% |
| 2018-12-31 | $0.78 B | 52.67% |
| 2017-12-31 | $0.51 B | -26.78% |
| 2016-12-31 | $0.69 B | 18.81% |
| 2015-12-31 | $0.58 B | 35.53% |
| 2014-12-31 | $0.43 B |